What Did You Buy Today?

[EricL]

(02-08-2017, 11:18 AM)divmenow Wrote: GILD is done. No growth, nothing in the pipeline. Listen to the conference call. One of the worst ones I ever heard. CEO should be fired. That stock has way more downside left. Nothing more then a bond now.

I though this was an excellent comment on Seeking Alpha:

Hang in there Bret. Without their HCV franchise, they would have revenues of $15-15.5 billion this year, EPS of around $5.50, and at least mid single digit growth. The DCF value would be in the $80s and the P/E would be around 15. So at $66, the market is giving their HCV business a negative value. Go figure.

Gilead certainly has some issues, but it does have significant cash flows and some good drugs other than the HCV franchise. I agree that share price isn't going anywhere until the declining revenue trend reverses, but I think the rumors of Gilead's demise are a bit premature.